UK doctors raise concerns about the safety of lipid-lowering agent inclisiran
Novartis faced a hurdle with the rollout of inclisiran (brand name: Leqvio), a cholesterol-lowering drug, in Europe. British medical groups have raised concerns over the agreement between Novartis and the British government to distribute the drug at a reduced price.…